Recruiting Lupus Nephritis Studies in Burlington
About Lupus Nephritis Clinical Trials in Burlington
Lupus nephritis is kidney inflammation caused by systemic lupus erythematosus, occurring in up to 60% of SLE patients. It can lead to kidney failure if untreated. Treatment includes immunosuppressive medications such as mycophenolate, cyclophosphamide, and newer agents like voclosporin.
There are currently 1 lupus nephritis clinical trials recruiting participants in Burlington, VT. These studies are seeking a combined 240 participants. Research is being sponsored by University of Vermont Medical Center. Clinical trial participation is free and participants receive study-related medical care at no cost.
Lupus Nephritis Clinical Trials in Burlington — FAQ
Are there lupus nephritis clinical trials in Burlington?
Yes, there are 1 lupus nephritis clinical trials currently recruiting in Burlington, VT. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Burlington?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Burlington research site will contact you about next steps.
Are clinical trials in Burlington free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Burlington studies also compensate for your time and travel.
What lupus nephritis treatments are being tested?
The 1 active trials in Burlington are testing new therapies including novel drugs, biologics, and treatment approaches for lupus nephritis.
Data updated July 13, 2026 from ClinicalTrials.gov